Aarti Drugs Ltd (AARTIDRUGS) — Board Meeting | 30 September 2026
Aarti Drugs announced the resignation of Chairman and CEO Prakash Patil effective September 30, 2026, following his early retirement request, and the promotion of CFO Adhish Patil to Managing Director effective October 1, 2026, with his relinquishment of the CFO role on September 30, 2026.
About Aarti Drugs Ltd (AARTIDRUGS)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when AARTIDRUGS files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track AARTIDRUGS — Free💡 Ask AI about this filing
📊 More AARTIDRUGS filings
- 🔴 Announcement — 1 October 2026Aarti Drugs Ltd has appointed three authorized persons effective October 1, 2026, to determine mater...
- Announcement — 29 September 2026Aarti Drugs Ltd announced that its trading window will close on October 1, 2026, remaining shut for ...
- 🟡 Board Meeting — 26 September 2026Aarti Drugs announced board changes at its September 26, 2026 AGM: Uday Patil retired as Whole-time ...
- 🟡 Board Meeting — 26 September 2026Aarti Drugs reported consolidated revenue of Rs. 2,568 crores for FY26, up 7% from Rs. 2,403 crores ...
- 🟡 Board Meeting — 26 September 2026Aarti Drugs held its 41st AGM on September 26, 2026 via video conference with 93 shareholders presen...
🔥 Also filed on 30 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when AARTIDRUGS files new disclosures
Track AARTIDRUGS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AARTIDRUGS — FreeFree account · 2 AI queries/day